Covered recipient · General Payments record
FREDRIC GROSS
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$7,175.80
- Reported across 308 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $474.46 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $186.78 | 3 |
| ABBVIE INC. | $117.17 | 6 |
| Mallinckrodt Hospital Products Inc. | $61.99 | 2 |
| Tarsus Pharmaceuticals, Inc. | $27.74 | 1 |
| LENSAR, Inc. | $23.18 | 1 |
| GLAUKOS CORPORATION | $22.55 | 1 |
| Ocular Therapeutix, Inc. | $21.12 | 1 |
| Thea Pharma Inc. | $13.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.62 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103842604 | CMS |
| ABBVIE INC. | $24.44 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103842606 | CMS |
| ABBVIE INC. | $16.17 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103842608 | CMS |
| ABBVIE INC. | $18.36 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103842610 | CMS |
| ABBVIE INC. | $20.72 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103842612 | CMS |
| ABBVIE INC. | $19.86 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103842614 | CMS |
| Alcon Vision LLC | $12.89 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110570867 | CMS |
| Alcon Vision LLC | $147.18 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110570871 | CMS |
| Alcon Vision LLC | $26.71 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110570869 | CMS |
| Glaukos Corporation | $22.55 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151981226 | CMS |
| LENSAR, Inc. | $23.18 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151783712 | CMS |
| Mallinckrodt Hospital Products Inc. | $36.53 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145079037 | CMS |
| Mallinckrodt Hospital Products Inc. | $25.46 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145079041 | CMS |
| Ocular Therapeutix, Inc. | $21.12 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148198687 | CMS |
| Tarsus Pharmaceuticals, Inc. | $27.74 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139100493 | CMS |
| Thea Pharma Inc. | $13.93 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074541249 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.